TY - JOUR
TI - MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortium
AU - Stratigos, A.J.
AU - Fargnoli, M.C.
AU - De Nicolo, A.
AU - Peris, K.
AU - Puig, S.
AU - Soura, E.
AU - Menin, C.
AU - Calista, D.
AU - Ghiorzo, P.
AU - Mandala, M.
AU - Massi, D.
AU - Rodolfo, M.
AU - Del Regno, L.
AU - Stefanaki, I.
AU - Gogas, H.
AU - Bataille, V.
AU - Tucker, M.A.
AU - Whiteman, D.
AU - Nagore, E.
AU - Landi, M.T.
JO - Journal of the European Academy of Dermatology and Venereology
PY - 2018
VL - 32
TODO - 12
SP - 2134-2141
PB - Wiley-Blackwell Publishing Ltd
SN - 0926-9959, 1468-3083
TODO - 10.1111/jdv.15208
TODO - Article;  clinical effectiveness;  clinical examination;  clinical feature;  family history;  follow up;  human;  lifestyle;  melanoma;  MelanoQ questionnaire;  phenotype;  priority journal;  questionnaire;  radiation exposure;  risk assessment;  risk factor;  ultraviolet radiation;  anamnesis;  consensus;  epidemiology;  melanoma;  procedures;  risk assessment;  skin tumor, Consensus;  Epidemiologic Methods;  Humans;  Life Style;  Medical History Taking;  Melanoma;  Radiation Exposure;  Risk Assessment;  Skin Neoplasms;  Surveys and Questionnaires;  Ultraviolet Rays
TODO - Background: Many melanoma observational studies have been carried out across different countries and geographic areas using heterogeneous assessments of epidemiologic risk factors and clinical variables. Aim: To develop a consensus questionnaire to standardize epidemiologic and clinical data collection for melanoma risk assessment. Methods: We used a stepwise strategy that included: compilation of variables from case–control datasets collected at various centres of the MelaNostrum Consortium; integration of variables from published case–control studies; consensus discussion of the collected items by MelaNostrum members; revision by independent experts; addition of online tools and image-based charts; questionnaire testing across centres and generation of a final draft. Results: We developed a core consensus questionnaire (MelanoQ) that includes four separate sections: A. general and demographic data; B. phenotypic and ultraviolet radiation exposure risk factors and lifestyle habits; C. clinical examination, medical and family history; and D. diagnostic data on melanoma (cases only). Accompanying online tools, informative tables, and image-based charts aid standardization. Different subsections of the questionnaire are designed for self-administration, patient interviews performed by a physician or study nurse, and data collection from medical records. Conclusions: The MelanoQ questionnaire is a useful tool for the collection and standardization of epidemiologic and clinical data across different studies, centres, cultures and languages. This will expedite ongoing efforts to compile high-quality data for pooled analyses or meta-analyses and offer a solid base for the design of clinical, epidemiologic and translational studies on melanoma. © 2018 European Academy of Dermatology and Venereology
ER -